Stockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade. It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.
The market opens at 10am (eastern time) and the data is taken at 10:15am, once every stock has commenced trading.
Stocks highlighted in yellow have made market-moving announcements (click headings to sort).
| Code | Name | Price | % Chg | Volume |
|---|---|---|---|---|
| QFY | Quantify Technology Holdings Ltd | 0.002 | +100.00% | 1.5M |
| RHY | Rhythm Biosciences Ltd | 0.082 | +49.09% | 43.0k |
| BNO | Bionomics Ltd | 0.05 | +34.29% | 722.3k |
| AZI | Alta Zinc Ltd | 0.004 | +33.33% | 2.2M |
| HSC | HomeStay Care Ltd | 0.004 | +33.33% | 125.0k |
| CCE | Carnegie Clean Energy Ltd | 0.002 | +33.33% | 500.0k |
| AVE | Avecho Biotechnology Ltd | 0.0025 | +25.00% | 500.0k |
| CUX | Crossland Strategic Metals Ltd | 0.005 | +25.00% | 276.0k |
| TSC | Twenty Seven Co Ltd | 0.005 | +25.00% | 345.0k |
| MSI | Multistack International Ltd | 0.01 | +22.22% | 15.0k |
Rhythm Biosciences (ASX:RHY), which is developing a blood-based test to replace the government funded faecal test for colorectal cancer, gave a positive update.
It told shareholders its key, lead biomarker was successfully validated, stabilised and proven to be reproducible and its technology was consequently de-risked significantly.
| Code | Name | Price | % Chg | Volume |
|---|---|---|---|---|
| ADD | Adavale Resources Ltd | 0.012 | -20.00% | 1.2M |
| NOX | Noxopharm Ltd | 0.22 | -18.52% | 1.8M |
| PGX | Primero Group Ltd | 0.14 | -17.14% | 101.0k |
| ELS | Elsight Ltd | 0.25 | -16.67% | 40.0k |
| TLM | Talisman Mining Ltd | 0.06 | -14.86% | 180.0k |
| RIM | Rimfire Pacific Mining NL | 0.003 | -14.29% | 3.4M |
| CNJ | Conico Ltd | 0.006 | -14.29% | 246.2k |
| LPD | Lepidico Ltd | 0.007 | -12.50% | 652.2k |
| IME | ImExHS Ltd | 0.02 | -12.50% | 1.9M |
| PYG | PayGroup Ltd | 0.51 | -12.07% | 6.0k |
Meanwhile Talisman Mining (ASX:TLM) revealed to shareholders its COVID-19 cutbacks.